Your Top Biotechnologies Antisense RNAi Therapeutics Questions Answered

PharmaSphere Emerging Biotechnologies - Antisense RNAi Therapeutics Market Analysis Telephone: +1 (800) 910-6452 Mail at: sales@researchbeam.com

Report Overview Summary

Emerging Biotechnologies Antisense RNAi Therapeutics Market Analysis report is an essential source of information and analysis on the RNA interference (RNAi) therapy field. Using detailed company data, deal analysis, corporate strategy, and market trends, It provides an in-depth analysis of the current and future growth drivers of the RNAi therapy market. The report discusses the key factors shaping and driving the RNAi therapy business, and provides insights into the competitive landscape and emerging strategies expected to significantly influence the market positions of companies currently involved in the development and commercialization of RNAi therapeutics.

Highlights Key Questions Answered What are the drivers of the RNAi therapy field?

Who are the leading companies involved in the development of RNAi therapies?

What are the major trends in RNAi clinical trials?

What specific therapeutic areas and indications are receiving the most clinical research?

What specific business development activities are taking place in terms of partnerships or mergers and acquisitions (M&As)?

Has investor confidence been restored in the antisense/RNAi therapy field?

Report Overview Scope This report provides market developments across the RNAi therapy field, including clinical trials, deals, and pipeline investments Investment examined from both industry and financial communities Clinical trials activity examined across phase of development, therapy area, and indication.

This report offers a deep dive into the synergies behind partnering and acquisition activities Deals examined across geography, entity type, company, financial advisor, phase of development, therapy area, indication, and mechanism of action Pipeline profiles of 25 leading biotech companies developing RNAi therapeutics

Reasons to buy Identify the key players in the RNAi market.

Analyze and track the strategies that companies are using to strengthen their position in the RNAi therapy field; independent source for due diligence.

Organize your sales and marketing strategy to identify companies with proprietary technologies in order to maximize opportunities for licensing, partnership, investment, or takeover.

Understand the flow of investment from capital markets into the RNAi therapy field.

Table of Contents 1 Table of Contents 6 1.1 List of Tables 9 1.2 List of Figures 11 2 Introduction 13 2.1 Report Scope 13 2.2 Companies Mentioned 14 2.3 Related Reports 14 3 Antisense RNAi Therapy Overview 15 3.1 What is Antisense Therapy? 15 3.2 The Second Era of RNAi 17 4 Clinical Trials 19 4.1 Overview 19 4.2 Company 20 4.3 Phase of Development 22 5 Company Analysis 36 5.1 Overview 36 5.2 Pipeline Profiles 39 6 Deals Landscape 88 6.1 Overview 88 6.1.1 Geography 89 6.2 Deal Type 103 7 Strategic Outlook 119

List of Tables Table 1: Alnylam Pharmaceuticals, Pipeline Programs, Phase I-III 41 Table 2: Alnylam Pharmaceuticals, Pipeline Programs, Preclinical 43 Table 3: Alnylam Pharmaceuticals, Pipeline Programs, Discovery 44 Table 4: Antisense Therapeutics 46 Table 5: Arrowhead Research Corporation 48 Table 6: AuraSense Therapeutics 50 Table 7: BioMarin Pharmaceuticals 52 Table 8: Dicerna Pharmaceuticals 54 Table 9: Gene Signal International SA 56 Table 10: Idera Pharmaceuticals 57 Table 11: InDex Pharmaceuticals AB 59 Table 12: Isarna Therapeutics GmbH 60 Table 13: Isis Pharmaceuticals, Pipeline Programs, Phase II-III 62 Table 14: Isis Pharmaceuticals, Pipeline Programs, Phase I 63 Table 15: Isis Pharmaceuticals, Pipeline Programs, Preclinical 64 Table 16: Miragen Therapeutics 66 Table 17: Mirna Therapeutics 67 Table 18: Moderna Therapeutics 68 Table 19: Mologen AG 70 Table 20: Oncogenex Pharmaceuticals 72 Table 21: Quark Pharmaceuticals 73 Table 22: Regulus Therapeutics 74 Table 23: RXi Pharmaceuticals 76

Report Ordering

Report Name: PharmaSphere Emerging Biotechnologies - Antisense RNAi Therapeutics Market Analysis Product Price User

Price

Single User

US $ 2546

Site User

US $ 5990

Global User

US $ 8985

To View Sample or Purchase Report

Contact Us

FOR MORE DETAILS Visit us at : http://www.researchbeam.com/pharmasphere-emerging-biotechnologies-antisense-rnaitherapeutics-analysis-market

Stay With Us At:

TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com

5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States